Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Anne R. Mccall

TitleAssociate Professor
InstitutionUniversity of Chicago
DepartmentRadiation and Cellular Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Anne R. McCall, MD, is an expert in radiation oncology, specializing in the treatment of breast cancer, gynecologic cancers, lymphoma, lung cancer, prostate cancer and solid tumors. She uses the leading-edge TrueBeam™ system to deliver a range of radiation therapies. This innovative technology is highly accurate -- allowing for faster, more comfortable treatment while minimizing damage to healthy tissue.

    In addition to her clinical work, Dr. McCall is interested in translational research -- the process by which discoveries made in the lab are brought to patient populations. She also has a strong interest in cost-benefit analyses, including the economic impact of shorter radiation regimens for patients diagnosed with early stage breast cancer.

    Dr. McCall is regularly named one of the "Best Doctors in America" by Best Doctors, Inc. and is an active member of the Leadership Board of the Prairie Land Region of the American Cancer Society.


    Collapse Biography 
    Collapse education and training
    Rush University Medical CollegeMD
    Loyola University Medical CenterInternship
    Loyola University Medical CenterResidency
    Loyola University Medical CenterFellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Arya R, Giurcanu M, Jutzy JM, Peters P, Daily EW, Golden DW, McCall AR, Howard AR, Hasan Y, Son CH. Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer. Am J Clin Oncol. 2021 11 01; 44(11):565-571. PMID: 34456239.
      View in: PubMed
    2. Arya R, Hong D, Schultz O, Jutzy JM, Cotangco K, Peters P, Daily EW, McCall AR, Howard AR, Hasan Y, Kothari R, Son CH. Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers. Adv Radiat Oncol. 2022 Mar-Apr; 7(2):100833. PMID: 35387422.
      View in: PubMed
    3. Lapen K, Cha E, Huang CC, Rosenberg DM, Rooney MK, McArthur M, Arya R, Son CH, McCall AR, Golden DW. The use of complementary and integrative therapies as adjunct interventions during radiotherapy: a systematic review. Support Care Cancer. 2021 Nov; 29(11):6201-6209. PMID: 33822240.
      View in: PubMed
    4. Rooney MK, Santiago G, Perni S, Horowitz DP, McCall AR, Einstein AJ, Jagsi R, Golden DW. Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis. J Patient Exp. 2021; 8:2374373521998847. PMID: 34179407.
      View in: PubMed
    5. Hou Y, Liang HL, Yu X, Liu Z, Cao X, Rao E, Huang X, Wang L, Li L, Bugno J, Fu Y, Chmura SJ, Wu W, Luo SZ, Zheng W, Arina A, Jutzy J, McCall AR, Vokes EE, Pitroda SP, Fu YX, Weichselbaum RR. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med. 2021 02 24; 13(582). PMID: 33627484.
      View in: PubMed
    6. McCall AR, Son CH. Young and High Risk. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1132-1133. PMID: 33220224.
      View in: PubMed
    7. Turchan WT, Arya R, Hight R, Al-Hallaq H, Dominello M, Joyce D, McCabe BP, McCall AR, Perevalova E, Stepaniak C, Yenice K, Burmeister J, Golden DW. Physician review of image registration and normal structure delineation. J Appl Clin Med Phys. 2020 Nov; 21(11):80-87. PMID: 32986307.
      View in: PubMed
    8. Hasan Y, Furtado L, Tergas A, Lee N, Brooks R, McCall A, Golden D, Jolly S, Fleming G, Morrow M, Kraynyak K, Sylvester A, Arif F, Levin M, Schwartz D, Boyer J, Skolnik J, Esser M, Kumar R, Bagarazzi M, Weichselbaum R, Spiotto M. A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 07 01; 107(3):487-498. PMID: 32151670.
      View in: PubMed
    9. Foster CC, Hasan Y, Son CH, McCall AR. In Reply to Trombetta. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):904-905. PMID: 31655659.
      View in: PubMed
    10. Arya R, Ichikawa T, Callender B, Schultz O, DePablo M, Novak K, Li S, Shenoy A, Everman A, Braunstein S, Dec I, Lala S, Feng Y, Biltz L, McCall AR, Golden DW. Communicating the External Beam Radiation Experience (CEBRE): Perceived Benefits of a Graphic Narrative Patient Education Tool. Pract Radiat Oncol. 2020 Jul - Aug; 10(4):e219-e226. PMID: 31520767.
      View in: PubMed
    11. Perni S, Rooney MK, Horowitz DP, Golden DW, McCall AR, Einstein AJ, Jagsi R. Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy. JAMA Oncol. 2019 Aug 01; 5(8):e190260. PMID: 31046122.
      View in: PubMed
    12. Foster CC, Hasan Y, Son CH, McCall AR. Linearly Accelerating Toward Gender Equity in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):974-978. PMID: 31327430.
      View in: PubMed
    13. Ni L, Koshy M, Connell P, Pitroda S, Golden DW, Al-Hallaq H, Hubert G, Kauffman G, McCall A, Malik R. Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation. J Thorac Dis. 2019 Jun; 11(6):2229-2239. PMID: 31372260.
      View in: PubMed
    14. Das LC, Golden DW, Perevalova E, Wong AC, De Nardo K, Stepaniak C, Joyce DS, McCabe BP, Hasan Y, Chmura SJ, McCall A. A feasibility study of 2-mm bolus for postmastectomy radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):161-166. PMID: 28089526.
      View in: PubMed
    15. Stiff PJ, Unger JM, Forman SJ, McCall AR, LeBlanc M, Nademanee AP, Bolwell BJ, Fisher RI. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial. Biol Blood Marrow Transplant. 2003 Aug; 9(8):529-39. PMID: 12931122.
      View in: PubMed
    16. Nieland JD, Loviscek K, Kono K, Albain KS, McCall AR, Potkul RK, Fisher SG, Velders MP, Petersson M, Kiessling R, Kast WM. PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. J Immunother. 1998 Jul; 21(4):317-22. PMID: 9672853.
      View in: PubMed
    17. Mohideen MN, McCall AR, Feinstein J, Sidrys J, Bricker P, Luka S. Factors that influence biochemical failure after radiation therapy for stage T1c prostate cancer. Am J Clin Oncol. 1998 Feb; 21(1):6-11. PMID: 9499260.
      View in: PubMed
    18. Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Gynecol Oncol. 1993 Feb; 48(2):232-5. PMID: 8428696.
      View in: PubMed
    Mccall's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (91) concept(s)
    _
    Co-Authors Expand Description
    See all (16) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _